首页> 外文期刊>The Journal of Infectious Diseases >Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood.
【24h】

Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood.

机译:通过对患者血液进行聚合酶链反应诊断有症状的内脏利什曼病。

获取原文
获取原文并翻译 | 示例
           

摘要

To diagnose symptomatic visceral leishmaniasis (kala-azar) using peripheral blood rather than tissue aspirates, a polymerase chain reaction (PCR) technique was developed for which the detection limit is 1 Leishmania-infected macrophage in 8 mL of blood. For Indian, Kenyan, or Brazilian patients with parasitologically confirmed kala-azar, 57 of 63 cases before treatment had blood that was PCR-positive (90% sensitivity). None of 40 clinically healthy persons had PCR-positive blood (100% specificity). Twelve (92%) of 13 clinically cured Indian patients had negative PCR reactions 1-6 months after treatment. This PCR procedure can provide a parasitologic diagnosis for the vast majority of kala-azar cases before therapy, may identify patients who have been successfully treated by chemotherapy, and should substantially reduce the need for invasive tests.
机译:为了使用外周血而不是组织抽吸物来诊断有症状的内脏利什曼病(黑热病),开发了一种聚合酶链反应(PCR)技术,其检测极限是在8 mL血液中感染了1株利什曼原虫感染的巨噬细胞。对于印度寄生虫病证实为黑热病的印度,肯尼亚或巴西患者,治疗前63例中有57例血液中PCR阳性(敏感性为90%)。 40名临床健康人士中没有一个具有PCR阳性血液(特异性为100%)。治疗后1-6个月,有13名(92%)临床治愈的印度患者PCR反应阴性。该PCR程序可在治疗前为绝大多数的黑热病病例提供寄生虫学诊断,可确定已通过化学疗法成功治疗的患者,并应大大减少对侵入性检查的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号